724 related articles for article (PubMed ID: 2187176)
1. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
2. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
[TBL] [Abstract][Full Text] [Related]
3. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome.
Hoekstra RE; Jackson JC; Myers TF; Frantz ID; Stern ME; Powers WF; Maurer M; Raye JR; Carrier ST; Gunkel JH
Pediatrics; 1991 Jul; 88(1):10-8. PubMed ID: 2057245
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
5. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
6. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
Dunn MS; Shennan AT; Zayack D; Possmayer F
Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
[TBL] [Abstract][Full Text] [Related]
7. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
[TBL] [Abstract][Full Text] [Related]
8. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome.
Liechty EA; Donovan E; Purohit D; Gilhooly J; Feldman B; Noguchi A; Denson SE; Sehgal SS; Gross I; Stevens D
Pediatrics; 1991 Jul; 88(1):19-28. PubMed ID: 2057268
[TBL] [Abstract][Full Text] [Related]
9. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome.
Gerstmann DR; Minton SD; Stoddard RA; Meredith KS; Monaco F; Bertrand JM; Battisti O; Langhendries JP; Francois A; Clark RH
Pediatrics; 1996 Dec; 98(6 Pt 1):1044-57. PubMed ID: 8951252
[TBL] [Abstract][Full Text] [Related]
10. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome.
Shapiro DL; Notter RH; Morin FC; Deluga KS; Golub LM; Sinkin RA; Weiss KI; Cox C
Pediatrics; 1985 Oct; 76(4):593-9. PubMed ID: 3900907
[TBL] [Abstract][Full Text] [Related]
12. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
13. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
[TBL] [Abstract][Full Text] [Related]
14. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study.
Geary C; Caskey M; Fonseca R; Malloy M
Pediatrics; 2008 Jan; 121(1):89-96. PubMed ID: 18166561
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
[TBL] [Abstract][Full Text] [Related]
16. Chronic lung disease of the very low birth weight infant--is it preventable?
Ogawa Y
Turk J Pediatr; 1998; 40(1):35-44. PubMed ID: 9673527
[TBL] [Abstract][Full Text] [Related]
17. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
[TBL] [Abstract][Full Text] [Related]
18. [The effect of bovine surfactant in premature infants with respiratory distress syndrome. Results of an open, multicenter study].
Gortner L; Bartmann P; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL; Versmold H
Z Geburtshilfe Perinatol; 1992; 196(4):159-64. PubMed ID: 1413943
[TBL] [Abstract][Full Text] [Related]
19. A prospective observational pilot study of synchronized nasal intermittent positive pressure ventilation (SNIPPV) as a primary mode of ventilation in infants > or = 28 weeks with respiratory distress syndrome (RDS).
Santin R; Brodsky N; Bhandari V
J Perinatol; 2004 Aug; 24(8):487-93. PubMed ID: 15141265
[TBL] [Abstract][Full Text] [Related]
20. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.
Finer NN; Carlo WA; Duara S; Fanaroff AA; Donovan EF; Wright LL; Kandefer S; Poole WK;
Pediatrics; 2004 Sep; 114(3):651-7. PubMed ID: 15342835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]